ScholarIQanswers from OpenAlex

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents

PaperCitations, authors & open-access status

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents have?

ScholarIQcitation count

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents has 1,865 citations in the OpenAlex counts ScholarIQ stores.

When was Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents published?

ScholarIQyear

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents has 1977 year in the ScholarIQ index.

What is the open-access status of Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents?

ScholarIQoa status

Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents has closed oa status in the ScholarIQ index.

What is the DOI of Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents?

ScholarIQdoi

The DOI for Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents is on the source record.

What is the PMID of Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents?

ScholarIQpmid

The PMID for Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents is on the source record.

What is the OpenAlex record for Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents?

ScholarIQopenalex

The OpenAlex for Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive Agents is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial